期刊文献+

蟾蜍令灵对裸鼠食管鳞癌原位移植瘤中P70S6K表达的影响

Effects of Bufalin on P70S6K in Orthotopic Transplanted Tumor of Esophageal Squamous Cell Carcinoma in Nude Mice
下载PDF
导出
摘要 背景食管癌是世界上最常见的消化道恶性肿瘤之一,近年研究发现,核糖体蛋白S6激酶(P70S6K)与其发生密切相关。笔者前期的研究表明,蟾蜍令灵(Bufalin)有明显的抗肿瘤作用。目的探讨Bufalin对裸鼠食管鳞癌原位移植瘤中P70S6K表达的影响。方法 Nu/Nu健康裸鼠36只,雌雄各半,采用随机数字表法分为4组,每组9只,即对照组(0.9%氯化钠溶液)、Bufalin低剂量(0.5 mg/kg,BL)组、Bufalin中剂量(1.0 mg/kg,BM)组、Bufalin高剂量(1.5 mg/kg,BH)组。观察经Bufalin治疗后裸鼠肿瘤生长情况;反转录PCR(RT-PCR)法检测裸鼠原位移植瘤中P70S6K mRNA的表达,Western blotting及免疫组化法检测裸鼠原位移植瘤中P70S6K和p-P70S6K相对表达量。结果 4组治疗前及治疗后第1天裸鼠体质量比较,差异无统计学意义(P>0.05)。4组治疗前肿瘤体积比较,差异无统计学意义(P>0.05);治疗后第15天肿瘤体积比较,差异有统计学意义(P<0.05)。治疗后第15天,BM组、BH组肿瘤体积均低于BL组和对照组(P<0.05)。3组肿瘤抑制率比较,差异有统计学意义(P<0.05)。4组P70S6K mRNA及P70S6K相对表达量比较,差异无统计学意义(F=0.634、0.119,P>0.05)。4组p-P70S6K相对表达量比较,差异有统计学意义(F=233.005,P<0.05)。结论 Bufalin对裸鼠食管鳞癌原位移植瘤具有抑制作用;Bufalin可以下调P70S6K的磷酸化水平,而P70S6K则不受影响,提示Bufalin可能通过抑制P70S6K活化而发挥作用。 Background Esophageal cancer is one of the most common gastrointestinal malignant tumors in the world. According to related studies in recent years,P70S6K is closely related to the occurrence of esophageal cancer. Some previous studies indicate that Bufalin has significant anti - tumor effect. Objectjve To investigate the effects of Bufalin on P70S6K in orthotopic transplanted tumor of esophageal squamous cell carcinoma in nude mice. Methods 36 Nu/ Nu healthy nude mice(18 were male,and 18 were female)were euqally divided into four groups by random number table method:control group (treated with 0. 9% sodium chloride solution),Bufalin low dose group(BL group,treated with 0. 5 mg/ kg Bufalin),Bufalin middle dose group( BM group,treated with 1. 0 mg/ kg Bufalin)and Bufalin high dose group( BH group,treated with 1. 5 mg/ kg Bufalin). The growth of xenografted tumors after Bufalin treatment was observed;the expression of P70S6K mRNA in transplanted tumor in nude mice was examined by RT - PCR method;the expression level of P70S6K and activation level of P70S6K in transplanted tumors of nude mice were detected by western blot and immunohistochemical methods. Results There was no significant difference in body weight of nude mice among four groups before treatment and one day after treatment(P 〉0. 05). There was no significant difference in tumor volume among four groups before treatment( P 〉 0. 05 );there was significant difference in tumor volume among four groups 15 days after treatment(P 〈 0. 05). Tumor volume of mice in BM group and BH group was significantly lower than that of mice in BL group and control group 15 days after treatment,respectively(P 〈0. 05). There was significant difference in tumor inhibition ratio among three groups( P 〈 0. 05). There was no significantnbsp;difference in relative expression levels of P70S6K mRNA and P70S6K among four groups(F = 0. 634,P 〉 0. 05). There was no significant difference in relative expression level of p - P70S6K among four groups( F = 233. 005,P 〈 0. 05). Conclusjon Bufalin has an anti - tumor effect on the orthotopic transplanted tumor of esophageal squamous cell carcinoma in nude mice;Bufalin can decrease the level of P70S6K phosphorylation,while P70S6K is not affected,which suggests that Bufalin may inhibit tumor growth through inhibiting the activation of P70S6K.
出处 《中国全科医学》 CAS CSCD 北大核心 2015年第15期1763-1767,共5页 Chinese General Practice
基金 国家自然科学基金资助项目(81303271)
关键词 食管肿瘤 蟾蜍令灵 核糖体蛋白质S6激酶类 70-kDa 原位移植瘤 Esophageal neoplasms Bufalin Ribosomal protein $6 kinases, 70 - kDa Orthotopictransplanted tumor
  • 相关文献

参考文献11

  • 1丁妍,王小玲,柳慧,刘月平.Bufalin促进人食管癌细胞ECA109凋亡的研究[J].食管外科电子杂志,2014(2):49-54. 被引量:1
  • 2Krenn L, Kopp B. Bufadienolides from animal and plant sources [J].Phytochemistry, 1988, 48 (1): 1 -29.
  • 3Yin PH, Liu X, Qiu YY, et al. Anti - tumor activity and apoptosis -regul - ation mechanisms of bufalin in various cancers : new hope forcancer patients [ J ]. Asian Pac J Cancer Prev, 2012, 13 (11):5339 -5343.
  • 4Kang XH, Xu ZY, Gong YB, et al. Bufalin reverses HGF - inducedresistance to EGFR - TKIs in EGFR mutant lung cancer cells viablockage of Met/PI3k/Akt pathway and induction of aaoptosis [ J ].Evid Based Complement Altemat Med, 2013,2013 : 243859.
  • 5武强,赵全年,宋卫东.PI3K/Akt/mTOR信号传导通路在肿瘤的研究进展[J].疾病监测与控制,2013,7(6):346-347. 被引量:25
  • 6Ou Y,Ma L, Ma L, et al. Overexpression of cyclin 61 antagonizes c-hemotherapeutic - induced apoptosis through PTEN/Akt pathway inhuman esophageal squamous cell carcinoma cells [ J ]. Cancer BiolTher, 2013, 14 (1) : 45 -55.
  • 7Tong Q, Zhang W, Jin S, et al. The relationship between p27(kipl) expression and the change of radiosensitivity of esophagealcarcinoma cells [ J]. Scand J Gastroenterol, 2011, 46 (2): 173-176.
  • 8Imotol, Yang ZQ, Pimkhaokham A, et al. Identification of cIAPl asa candidate target gene within an amplicon at 11 q22 in esophagealsquamous cell carcinomas [J]. Cancer Res, 2001, 61 (18): 6629-6634.
  • 9Dhar R, Persaud SD, Mireles JR, et al. Proteolytic cleavage of p70ribosomal S6 kinase by caspase - 3 during DNA damage - inducedapoptosis [J]. Biochemistry, 2009 , 48 ( 7) : 1474-1480.
  • 10Fingar DC, Richardson CJ, Tee AR, et al. mTOR controls cellcycle progression through its cell growth effectors S6KI and 4EBP1/Eu - karyofi - c translation initiation factor 4E [ J] . Mol Cell Biol,2004 , 24 (1) ; 200-216.

二级参考文献11

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部